|
SKA3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.31909999274194E-09 |
| Normal-vs-Stage2 |
7.618400E-03 |
| Normal-vs-Stage3 |
1.91740999999634E-05 |
| Normal-vs-Stage4 |
4.802800E-03 |
| Stage1-vs-Stage2 |
4.776600E-01 |
| Stage1-vs-Stage3 |
1.199090E-03 |
| Stage1-vs-Stage4 |
2.516100E-02 |
| Stage2-vs-Stage3 |
1.067540E-02 |
| Stage2-vs-Stage4 |
4.838000E-02 |
| Stage3-vs-Stage4 |
7.768600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6278089987054E-12 |
| Normal-vs-AfricanAmerican |
2.77110000002079E-06 |
| Normal-vs-Asian |
3.665900E-02 |
| Caucasian-vs-AfricanAmerican |
6.856400E-01 |
| Caucasian-vs-Asian |
2.274200E-01 |
| AfricanAmerican-vs-Asian |
1.363420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4432899320127E-15 |
| Normal-vs-Female |
2.17640000022001E-07 |
| Male-vs-Female |
8.080500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.182190E-04 |
| Normal-vs-Extreme_Weight |
2.43479999495477E-08 |
| Normal-vs-Obese |
4.11090000040915E-07 |
| Normal-vs-Extreme_Obese |
1.604230E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.194600E-01 |
| Normal_Weight-vs-Obese |
7.349400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.536400E-03 |
| Extreme_Weight-vs-Obese |
6.476000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.562600E-04 |
| Obese-vs-Extreme_Obese |
7.93730000000492E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.834200E-04 |
| Normal-vs-Age(41-60Yrs) |
6.21791507171565E-12 |
| Normal-vs-Age(61-80Yrs) |
1.64740000530017E-08 |
| Normal-vs-Age(81-100Yrs) |
1.734160E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.251400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.451800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.702000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.024600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.670300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.452200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.48672218769752E-13 |
| Normal-VS-Type2 PRCC |
1.44649999977986E-07 |
| Normal-VS-KIRP CIMP |
2.136400E-03 |
| Normal-VS-Unclassified PRCC |
3.045400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.291730E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.416700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.513170E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.164600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.058000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.787850E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51059999997649E-06 |
| Normal-vs-N1 |
3.6755999999194E-07 |
| Normal-vs-N2 |
7.142000E-02 |
| N0-vs-N1 |
8.22890000000687E-05 |
| N0-vs-N2 |
7.407000E-01 |
| N1-vs-N2 |
8.801600E-02 |
|
|
